Skip to main content

Prevention and Treatment of Atherosclerosis

Improving State-of-the-Art Management and Search for Novel Targets

  • Book
  • Open Access
  • © 2022

You have full access to this open access Book

Overview

  • Summarizes the latest studies on the management of cardiovascular risk factors
  • Reviews exhaustively the key recent research into the pathogenesis of atherosclerotic cardiovascular diseases
  • Outlines various strategies of identifying and validating novel targets for prevention and treatment of atherosclerosis
  • This book is open access, which means that you have free and unlimited access

Part of the book series: Handbook of Experimental Pharmacology (HEP, volume 270)

Buy print copy

Softcover Book USD 49.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 59.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Table of contents (20 chapters)

  1. Improving the Treatment of Established Targets

  2. Novel Drug Developments Addressing Predefined Targets

  3. Hypothesis Based Approaches to Unravel Novel Targets

  4. Hypothesis-free Approaches to Unravel Novel Targets

Keywords

About this book

This open access book is supported by the European Atherosclerosis Society Association (EAS). This follow-up edition of the well-received Handbook volume 'Atherosclerosis: Diet and Drugs'  reflects the state-of-the-art and most recent developments in atherosclerosis research. Outstanding international experts give a comprehensive overview of the field covering topics, such as improving the treatment focusing on established targets, novel drug developments addressing pre-defined targets, hypothesis-based and hypothesis-free approaches to unravel novel targets. 

Editors and Affiliations

  • Institute of Clinical Chemistry, University Hospital Zurich, Zurich, Switzerland

    Arnold von Eckardstein

  • Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria

    Christoph J. Binder

About the editors

Previous publications in the Handbook of Experimental Pharmacology series co-edited by Prof. ​Arnold von Eckardstein : Atherosclerosis: Diet and Drugs, 2005, Arnold von Eckardstein; High Density Lipoproteins, 2015, Arnold von Eckardstein, Dimitris Kardassis (eds.), Open Access

Bibliographic Information

  • Book Title: Prevention and Treatment of Atherosclerosis

  • Book Subtitle: Improving State-of-the-Art Management and Search for Novel Targets

  • Editors: Arnold von Eckardstein, Christoph J. Binder

  • Series Title: Handbook of Experimental Pharmacology

  • DOI: https://doi.org/10.1007/978-3-030-86076-9

  • Publisher: Springer Cham

  • eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)

  • Copyright Information: The Editor(s) (if applicable) and The Author(s) 2022

  • Hardcover ISBN: 978-3-030-86075-2Published: 01 February 2022

  • Softcover ISBN: 978-3-030-86078-3Published: 01 February 2022

  • eBook ISBN: 978-3-030-86076-9Published: 31 January 2022

  • Series ISSN: 0171-2004

  • Series E-ISSN: 1865-0325

  • Edition Number: 1

  • Number of Pages: X, 538

  • Number of Illustrations: 3 b/w illustrations, 37 illustrations in colour

  • Topics: Cardiology, Pharmacology/Toxicology, Angiology, Metabolic Diseases

Publish with us